H, A. A. A., & Fahad, A. A. (2021). Approved and marketed nanoparticles for disease targeting and applications in COVID-19. De Gruyter.
Cita Chicago Style (17a ed.)H, Abdellatif Ahmed A., y Alsowinea Abdullah Fahad. Approved and Marketed Nanoparticles for Disease Targeting and Applications in COVID-19. De Gruyter, 2021.
Cita MLA (8a ed.)H, Abdellatif Ahmed A., y Alsowinea Abdullah Fahad. Approved and Marketed Nanoparticles for Disease Targeting and Applications in COVID-19. De Gruyter, 2021.
Precaución: Estas citas no son 100% exactas.